Zaroon's research while affiliated with University of the Punjab and other places

Forensic musicology is the scientific study of music in a legal context. It can be used to help identify the composer of a piece of music, to determine the ownership of a copyright, or to resolve disputes over the use of musical works. Forensic musicologists may also be called upon to give expert testimony in court cases involving questions of music. Forensic musicology is a relatively new field, and there are no formal educations or training requirements for becoming a forensic musicologist. However, most forensic musicologists have advanced degrees in music theory, musicology, or a related field, and many also have experience working as professional musicians. Forensic musicologists use their knowledge of musical composition, history, and performance to answer questions raised in legal cases. Forensic musicologists typically collaborate with attorneys, judges, and other legal professionals to provide expert testimony or analysis in court cases. In some cases, they may also be asked to testify in front of a grand jury or give depositions. Forensic mu�sicologists may also be consulted by law enforcement agencies to help identify unknown pieces of music or to authenticate record�ings. This review will focus on the application of forensic musicol�ogy in civil and criminal case

Every single person has distinct characteristics that set them apart from others [1]. In connection to the forensic inquiry, identifying a person is a crucial and di cult task. However, the most frequently used methods for ensuring secure and speedy identi cation are ngerprinting and DNA testing. Other techniques, such as identi cation of age or sex, height or weight measurement, post-mortem reports, anthropometry, rugae patterns, are also occasionally used [2-4]. Since DNA testing is not frequently available in developing nations, ngerprints and

Context: Epidermal growth factor receptor (EGFR), a member of the HER receptor family, is over expressed in various cancer cells. Using tumor-specific antibodies to deliver cytotoxic agents directly to the tumor cells is an effective treatment strategy. Targeted therapy by fusing anti-EGFR scFv with tumor-specific cytokines promises the emergence of a new era. Methods: We designed a novel immuno-apoptotic fusion protein, anti-EGFR scFv-IL-24, consisting of a specific cancer cell targeting antibody and recombinant cytokine IL-24 to explore its anti-cancerous potential. Amino acid sequences of both anti-EGFR scFv and IL-24 were fused using a specific rigid linker. In silico characterization of the designed fusion protein like to predict the primary, secondary, physiochemical properties, quality, and structural validation using online bioinformatic tools. The newly designed fusion protein consists of 402 amino acids that showed good quality with a predicted value of 76.7% having 81.5% residues in the most favored region as predicted by ERRAT2 and Ramachandran plot analysis. Docking and simulation studies were performed using HDOCK and Desmond module of Schrodinger. All the parameters of quality, validity, interaction analysis, and stability suggested that the fused molecule is fully operational and functional. The results of the study support that the anti-EGFR scFv-IL-24 fused protein could be proved as a novel candidate to combat cancer.